![Armand Keating](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Armand Keating
Chief Tech/Sci/R&D Officer at ROQUEFORT THERAPEUTICS PLC
Armand Keating active positions
Companies | Position | Start | End |
---|---|---|---|
ROQUEFORT THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 16/09/2022 | - |
Tissue Regeneration Therapeutics, Inc.
![]() Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada. | Director/Board Member | - | - |
Pancella Therapeutics, Inc.
![]() Pancella Therapeutics, Inc. BiotechnologyHealth Technology Pancella Therapeutics, Inc. develops novel therapies for geno dermatoses. The company is headquartered in Toronto, Canada. | Director/Board Member | - | - |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Director/Board Member | - | - |
Founder | 01/01/2015 | - |
Career history of Armand Keating
Former positions of Armand Keating
Companies | Position | Start | End |
---|---|---|---|
Princess Margaret Hospital | Chief Tech/Sci/R&D Officer | - | - |
American Society of Hematology
![]() American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | President | - | - |
American Society for Blood & Marrow Transplantation | President | - | - |
University of Toronto | Corporate Officer/Principal | - | - |
Statistics
International
Canada | 6 |
United States | 3 |
United Kingdom | 2 |
Operational
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
President | 2 |
Sectoral
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ROQUEFORT THERAPEUTICS PLC | Health Technology |
Private companies | 6 |
---|---|
Tissue Regeneration Therapeutics, Inc.
![]() Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada. | Health Technology |
Pancella Therapeutics, Inc.
![]() Pancella Therapeutics, Inc. BiotechnologyHealth Technology Pancella Therapeutics, Inc. develops novel therapies for geno dermatoses. The company is headquartered in Toronto, Canada. | Health Technology |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Commercial Services |
American Society of Hematology
![]() American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
American Society for Blood & Marrow Transplantation | |
Princess Margaret Hospital |
- Stock Market
- Insiders
- Armand Keating
- Experience